Lycia Therapeutics, Inc. ($LYCA)
Filing Information
| Accession Number | 0001231919-26-001503 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 27, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
28,375,902
Total Value
$37,653,863.30
P&L
+43.4% (+$16,345,752.70)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10% Owner | Common Stock | โ | Oct 23, 2026 | Purchase | 24,560 | $25.68 | $630,700.80 | 24,560 | Indirect | By Funds | View Details | |
10% Owner | Common Stock | โ | Oct 23, 2026 | Purchase | 28,379 | $26.11 | $740,975.69 | 52,939 | Indirect | By Funds | View Details | |
10% Owner | Common Stock | โ | Oct 26, 2026 | Conversion | 4,779,793 | โ | โ | 4,832,732 | Indirect | By Funds | View Details | |
10% Owner | Common Stock | โ | Oct 26, 2026 | Purchase | 1,944,444 | $18.00 | $34,999,992.00 | 6,777,176 | Indirect | By Funds | View Details | |
10% Owner | Common Stock | โ | Oct 26, 2026 | Purchase | 8,261 | $26.97 | $222,799.17 | 6,785,437 | Indirect | By Funds | View Details | |
10% Owner | Common Stock | โ | Oct 27, 2026 | Purchase | 8,729 | $25.84 | $225,557.36 | 6,794,166 | Indirect | By Funds | View Details | |
10% Owner | Common Stock | โ | Oct 27, 2026 | Purchase | 31,067 | $26.84 | $833,838.28 | 6,825,233 | Indirect | By Funds | View Details | |
10% Owner | Series C Preferred Stock | Derivative | Oct 26, 2026 | Conversion | 17,142,578 | $0.00 | $0.00 | 0 | Indirect | By Funds | View Details | |
10% Owner | Series D Preferred Stock | Derivative | Oct 26, 2026 | Conversion | 4,408,091 | $0.00 | $0.00 | 0 | Indirect | By Funds | View Details |